Photo of Professor Maher Gandhi goes here

Research into blood cancer will be boosted with a new high-level appointment at the University of Queensland Diamantina Institute.

12 August 2014

Research designed to help patients with cancer, schizophrenia, stroke and depression features among projects that were today awarded new funding at The University of Queensland.

23 October 2013
Professor Maree Smith . . . has two game-changing pain therapies close to being available on the global market

A vaccine against cervical cancer, a global parenting program, new forms of pain relief, better yielding crops and improved medical imaging are some of many high-impact outcomes of University of Queensland research.

19 September 2013
AIBN Director Professor Peter Gray.

An international collaboration involving the development of next-generation of smart medicines in Brisbane has received a boost, with $485,000 in State Government funding

19 June 2012
Professor Matt Brown (Director of the UQ Diamantina Institute) talks with Professor Ian Frazer (CEO of the TRI) and Premier Anna Bligh about UQDI’s state-of-the-art genomics facilities

The vision of a specialised centre to better understand and treat head and neck cancers will come to fruition — thanks to $15 million funding from Atlantic Philanthropies, the Queensland Government and the Princess Alexandra Hospital.

9 March 2012

UniQuest, The University of Queensland’s main research commercialisation company, announced today that it has facilitated a strategic research collaboration agreement with Janssen-Cilag Pty Ltd in Australia, one of the Janssen pharmaceutical...

17 January 2012

Professor Ian Frazer, who was named Australian of the Year in 2006 for his development of the human papillomavirus (HPV) cervical cancer vaccines, has become one of the most recent members of the Australian Academy of Science, alongside a Nobel...

14 December 2011

A University of Queensland (UQ) start-up company, Coridon Pty Ltd, established to commercialise Professor Ian Frazer’s work in developing next generation DNA vaccines, has successfully completed pre-clinical efficacy testing of its prototype Herpes...

24 October 2011